VC DEALS ANALYSIS: 2015 beats 2014 by $300m-plus in month with no heart
This article was originally published in Clinica
With only a month left until the end of the year, the venture financing climate in 2015 to date has already proven to be more favorable than that of last year.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.